Graft-Versus-Host Disease Serum

Overview +

Human Graft-Versus-Host Disease Serum for Research

Our Graft-Versus-Host Disease Serum is sourced from IRB-consented donors clinically diagnosed with Graft-Versus-Host Disease. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for disease-specific and immunological studies focused on gvhd.

Product Features

  • Collected from clinically confirmed Graft-Versus-Host Disease donors
  • Research Use Only (RUO)
  • IRB-approved protocols with documented consent

Donor Metadata

  • Diagnosis confirmation
  • Age, sex assigned at birth, and ethnicity
  • Donor-reported medical history and comorbidities

Applications

  • Biomarker discovery for gvhd
  • Serum cytokine and protein profiling
  • Therapeutic candidate screening and validation

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Graft-Versus-Host Disease serum is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.

Data and Testing +

Data and Testing with Every Sample

  • Donor demographics
  • Donor-reported allergies
  • Donor-reported infectious disease history

Compliance & Quality Assured

For quality and compliance related information, please visit Sanguine quality and compliance page.

For privacy related information, please visit Sanguine privacy policy page.